# Immorta Bio Demonstrates "Serial Killing" of Senescent Cells by SenoMune™-0257-Stimulated T Cells

- Source: PR Newswire General Business
- Published: 2026-11-20T13:08:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/immorta-bio-demonstrates-serial-killing-of-senescent-cells-by-senomune-0257stimulated-t-cells-302946967.html
- Canonical: https://groundlevelnews.com/story/immorta-bio-demonstrates-serial-killing-of-senescent-cells-by-senomune-2c7959/

Laboratory studies observed a single CD8+ T cell eliminate up to 11 senescent cells, with no detectable activity against tested non-senescent controls MIAMI, Nov. 20, 2026 /PRNewswire/ -- Immorta Bio, Inc., a clinical-stage biotechnology company developing therapies to restore youthful...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire General Business._
